Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

The new protocol using Cellutome™ and RCM safely assesses wound healing in detail.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Dupilumab may help treat hair loss and skin color loss in some patients with atopic dermatitis.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Radiesse is a versatile facial injectable used for cosmetic improvements and long-term collagen production, with careful dosing needed to prevent complications.

Squaric acid dibutylester effectively treats alopecia areata.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Ocrelizumab may cause delayed hair loss in some patients.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Semaglutide helps obese PCOS patients lose weight and improve health.

CS12192 effectively treats alopecia areata with better safety than current options.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

HAC and BAC improve skin targeting and reduce diffusion without causing irritation.

Using both bone marrow concentrate and platelet-rich plasma together improves skin wound healing in mice.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Multiparametric ultrasound effectively monitors scalp changes after using vasoconstrictive cosmetics.

Cubosomes improve drug delivery for skin and eye diseases by enhancing adhesion, retention, and release.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.